Showing results (151-160 of 362) with videos related to
Sort By:
Pageof 37
Journal of Cancer Research and Clinical Oncology|January 1, 1988
Plasma concentrations of medroxyprogesterone acetate and megesterol acetate during long-term follow-up in patients treated for metastatic breast cancerA A Miller, R Becher, C G SchmidtJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2001
Irinotecan in the treatment of colorectal cancer: clinical overviewU Vanhoefer, A Harstrick, W Achterrath, et al.Cancer Gene Therapy|August 5, 2000
Transformation-defective adenovirus 5 E1A mutants exhibit antioncogenic properties in human BLM melanoma cellsA Dickopp, H Esche, G Swart, et al.Journal of Neurochemistry|November 18, 2000
Transient expression of NMDA receptor subunit NR2B in the developing rat heartS Seeber, K Becker, T Rau, et al.Experimental Hematology|May 20, 1998
Recombinant gene products of two natural variants of the human cytidine deaminase gene confer different deamination rates of cytarabine in vitroH C Kirch, J Schröder, H Hoppe, et al.European Journal of Haematology|April 1, 1997
Recombinant human erythropoietin in the treatment of cancer-related anaemiaC Kasper, A Terhaar, A Fosså, et al.Leukemia Research|November 27, 1999
Transfer of the cytidine deaminase cDNA into hematopoietic cellsM Flasshove, W Frings, J K Schröder, et al.Blood|July 9, 1999
The risk of residual molecular and cytogenetic disease in patients with Philadelphia-chromosome positive first chronic phase chronic myelogenous leukemia is reduced after transplantation of allogeneic peripheral blood stem cells compared with bone marrowA H Elmaagacli, D W Beelen, B Opalka, et al.Annals of Hematology|September 14, 2000
The amount of BCR-ABL fusion transcripts detected by the real-time quantitative polymerase chain reaction method in patients with Philadelphia chromosome positive chronic myeloid leukemia correlates with the disease stageA H Elmaagacli, D W Beelen, B Opalka, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2001
Survival of tumor cells in stem cell preparations and bone marrow of patients with high-risk or metastatic breast cancer after receiving dose-intensive or high-dose chemotherapyS Kasimir-Bauer, S Mayer, P Bojko, et al.Pageof 37